Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M48,127Revenue $M6,022Net Margin (%)57.8Z-Score8.3
Enterprise Value $M42,048EPS $17.3Operating Margin %28.3F-Score7
P/E(ttm))15.2Cash Flow Per Share $7.1Pre-tax Margin (%)56.7Higher ROA y-yY
Price/Book5.910-y EBITDA Growth Rate %0Quick Ratio1.5Cash flow > EarningsY
Price/Sales7.95-y EBITDA Growth Rate %27.7Current Ratio1.7Lower Leverage y-yY
Price/Cash Flow12.9y-y EBITDA Growth Rate %78.6ROA % (ttm)31.2Higher Current Ratio y-yN
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)53.7Less Shares Outstanding y-yY
Payout Ratio %4.0Shares Outstanding M200ROI % (ttm)11.5Gross Margin Increase y-yN

Gurus Latest Trades with SHPG

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
SHPGLeon Cooperman 2014-12-31 Buy 1.7%$170.49 - $262.71
($211.39)
$ 240.9712%New holding473,237
SHPGJohn Paulson 2014-12-31 Reduce-0.77%$170.49 - $262.71
($211.41)
$ 240.9712%Reduce -7.93%8,328,304
SHPGDaniel Loeb 2014-12-31 Reduce-0.73%$170.49 - $262.71
($211.58)
$ 240.9712%Reduce -33.33%500,000
SHPGAndreas Halvorsen 2014-12-31 Buy 0.52%$170.49 - $262.71
($211.41)
$ 240.9712%New holding529,784
SHPGJean-Marie Eveillard 2014-12-31 Add0.04%$170.49 - $262.71
($211.58)
$ 240.9712%Add 453.24%82,986
SHPGMario Gabelli 2014-12-31 Reduce-0.03%$170.49 - $262.71
($211.58)
$ 240.9712%Reduce -57.13%16,225
SHPGKen Fisher 2014-12-31 Add0.01%$170.49 - $262.71
($211.58)
$ 240.9712%Add 416.24%14,594
SHPGRichard Perry 2014-12-31 Sold Out -6.5%$170.49 - $262.71
($211.58)
$ 240.9712%Sold Out0
SHPGDavid Tepper 2014-12-31 Sold Out -0.71%$170.49 - $262.71
($211.58)
$ 240.9712%Sold Out0
SHPGRichard Perry 2014-09-30 Buy 6.5%$231.98 - $262.64
($248.14)
$ 240.97-3%New holding695,800
SHPGJohn Paulson 2014-09-30 Add6.09%$231.98 - $262.64
($248.14)
$ 240.97-3%Add 168.70%9,046,000
SHPGDaniel Loeb 2014-09-30 Buy 2.2%$231.98 - $262.64
($248.14)
$ 240.97-3%New holding750,000
SHPGDavid Tepper 2014-09-30 Buy 0.71%$231.98 - $262.64
($248.14)
$ 240.97-3%New holding185,944
SHPGMario Gabelli 2014-09-30 Buy 0.05%$231.98 - $262.64
($248.14)
$ 240.97-3%New holding37,850
SHPGJean-Marie Eveillard 2014-09-30 Buy 0.01%$231.98 - $262.64
($248.14)
$ 240.97-3%New holding15,000
SHPGJohn Paulson 2014-06-30 Add0.84%$142.83 - $234.98
($172.9)
$ 240.9728%Add 33.07%3,366,539
SHPGAndreas Halvorsen 2014-06-30 Sold Out -0.25%$142.83 - $234.98
($172.9)
$ 240.9728%Sold Out0
SHPGAndreas Halvorsen 2014-03-31 Reduce-0.55%$139.18 - $171.77
($153.85)
$ 240.9736%Reduce -67.31%399,840
SHPGAndreas Halvorsen 2013-12-31 Add0.25%$113.87 - $140.87
($131.38)
$ 240.9745%Add 43.92%1,223,005
SHPGJohn Paulson 2013-12-31 Reduce-0.24%$113.87 - $140.87
($131.38)
$ 240.9745%Reduce -11.03%2,529,854
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

SHPG is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


SHPG: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about SHPG :

    Quarterly/Annual Reports about SHPG:

    News about SHPG:

    Articles On GuruFocus.com
    Top Stock Picks Among Companies That Recently Increased Dividends Mar 09 2015 
    AbbVie To Acquire Biopharmaceutical Firm Pharmacyclics Mar 06 2015 
    Valeant Pharmaceuticals Finally Zeros In On Salix Pharmaceuticals Feb 24 2015 
    Three Pharma Majors In The Run To Acquire Salix Feb 16 2015 
    Pioneer Investments Purchases Time Warner Cable, Kohl's in Q4 Feb 10 2015 
    AbbVie’s Q4 Reflects Its Tremendous Growth Potential Going Forward Feb 04 2015 
    Shire Set To Acquire NPS Pharmaceuticals for $5.2 Billion Jan 15 2015 
    Invesco European Growth Fund Comments on Shire PLC Dec 30 2014 
    Invesco European Growth Fund Q4 2014 Management’s Discussion Dec 30 2014 
    Activist Investor Dan Loeb Stays Active in Third Quarter Dec 08 2014 


    More From Other Websites
    2014 Annual Report - DTR 6.3.5 Disclosure Mar 26 2015
    Cincinnati Children’s inks deal with Shire to develop drugs Mar 26 2015
    3 Attractive Growth Shares For My 2015 ISA Watchlist: easyjet Plc, ARM Holdings Plc And Shire Plc Mar 26 2015
    Shire and Cincinnati Children’s Establish Rare Disease Research Collaboration Mar 26 2015
    Shire and Cincinnati Children's Establish Rare Disease Research Collaboration Mar 26 2015
    4 Top-Ranked Health Care ETFs for a Healthy Portfolio - ETF News And Commentary Mar 25 2015
    Are SkyePharma PLC And Spire Healthcare Group PLC Better Buys Than Shire PLC And BTG plc? Mar 24 2015
    Vyvanse® (lisdexamfetamine dimesylate) Capsules (CII) 10 mg Now Available as a Titration Dose Mar 23 2015
    Viking Global Exited Its Position in AbbVie Mar 20 2015
    Amicus Up As FDA, EU Green-light Quick Drug Filings Mar 19 2015
    RiverVest leads venture capital exits to record highs Mar 18 2015
    Should Investors Buy These 4 ‘Bad News’ Stocks for Big Gains? Mar 16 2015
    These Positions Lost More than 20% of their Hedge Fund Holders Mar 13 2015
    Teachers fund exits position in Shire Mar 13 2015
    Is Bioquell plc The Perfect Partner For Shire PLC And BTG plc In Your Portfolio? Mar 12 2015
    Billionaire John Paulson’s Long-Term Bets: Time Warner Cable Inc, Mallinckrodt PLC and More Mar 12 2015
    New Report From The NEJM On Clinical Trial Reporting Further Tarnishes Biopharma's Image Mar 11 2015
    4 Top Pharmaceutical Stocks to Buy for Market Safety Mar 11 2015
    Cowen On Shire: 'Add Aggressively' Mar 10 2015
    SHIRE PLC Files SEC form 8-K, Financial Statements and Exhibits Mar 10 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK